Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Feb 23, 2009 brown michael s Director Option Execute 5,000 7.66
Nov 5, 2007 brown michael s Director Option Execute 10,000 7.91
Sep 9, 2008 brown michael s Director Option Execute 5,000 7.66
Jul 1, 2011 brown michael s Director Option Execute 25,000 15.80 - 28.81
Mar 30, 2011 brown michael s Director Option Execute 5,000 15.01
Mar 9, 2011 brown michael s Director Option Execute 5,000 15.01
Jan 18, 2011 brown michael s Director Option Execute 10,000 15.01 - 18.80
May 18, 2010 brown michael s Director Option Execute 5,000 25.43
Oct 6, 2010 brown michael s Director Option Execute 5,000 18.80
Dec 17, 2010 brown michael s Director Option Execute 5,000 18.80
Mar 1, 2012 brown michael s Director Option Execute 20,000 15.80 - 19.69
Sep 7, 2011 brown michael s Director Option Execute 5,000 9.17
Sep 8, 2011 brown michael s Director Option Execute 5,000 9.17
Sep 21, 2011 brown michael s Director Option Execute 5,000 9.17
Oct 25, 2012 brown michael s Director Option Execute 2,000 23.84
Oct 26, 2012 brown michael s Director Option Execute 3,000 23.84
Nov 14, 2012 brown michael s Director Option Execute 7,000 23.84
Aug 6, 2012 brown michael s Director Option Execute 3,000 23.84
May 15, 2013 brown michael s Director Option Execute 15,000 24.41
Mar 21, 2013 brown michael s Director Option Execute 15,000 18.61
Showing 81-100 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)